Medtronic pump study for diabetes and gastroparesis
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether the Medtronic 780G insulin pump helps people with type 1 diabetes and gastroparesis (slowed stomach emptying) control their blood sugar better than their usual care. It requires continuous glucose monitoring and certain blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 1 diabetes for at least 1 year with a steady insulin plan for 2 months
- Your average blood sugar (A1c) is 8.0% or higher
- You have been diagnosed with gastroparesis by a doctor
- You are willing to use the Medtronic 780G pump and continuous glucose monitor
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a follow-up study for people who already took part in the original Steno780G study. It will check how participants are doing over time.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial is testing the best timing for bolus insulin doses (before vs. during a meal) in people using the MiniMed 780G pump. It may help you learn how to better manage your blood sugar after meals.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
This trial tests an automated insulin pump system for people with diabetes who also have advanced kidney disease. It may help manage blood sugar more easily.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.